Pneumocystis pneumonia (PCP) is a life-threatening fungal disease that can occur in dogs. The aim of this study was to provide a preliminary genetic characterisation of Pneumocystis carinii f.sp.'canis' (P. canis) in dogs and thereby develop a reliable molecular protocol to definitively diagnose canine PCP. We investigated P. canis in a variety of lung specimens from dogs with confirmed or strongly suspected PCP (Group 1, n = 16), dogs with non-PCP lower respiratory tract problems (Group 2, n = 65) and dogs not suspected of having PCP or other lower respiratory diseases (Group 3, n = 11). Presence of Pneumocystis DNA was determined by nested PCR of the large and small mitochondrial subunit rRNA loci and by a real-time quantitative polymerase chain reaction (qPCR) assay developed using a new set of primers. Molecular results were correlated with the presence of Pneumocystis morphotypes detected in cytological/histological preparations. Pneumocystis DNA was amplified from 13/16 PCP-suspected dogs (Group 1) and from 4/76 dogs of control Groups 2 and 3 (combined). The latter four dogs were thought to have been colonized by P. canis. Comparison of C T values in 'infected' versus 'colonized' dogs was consistent with this notion, with a distinct difference in molecular burden between groups (C T ≤ 26 versus C T range (26 <C T < 35), respectively). Phylogenetic analyses showed that P. canis is specifically 'canine' associated, being separated from other mammalian Pneumocystis species, thereby confirming the accuracy of qPCR amplicon for Pneumocystis in dogs. Using qPCR, Pneumocystis DNA can be detected in specimens from the respiratory tract and a C T value can be interpreted to distinguish infection versus colonization.
Introduction
Members of the fungal genus Pneumocystis comprise fungi that can act as commensals, opportunists or pathogens of the respiratory tract in mammalian species, 1 including dogs. 2 The species specificity and host-obligate nature of
Pneumocystis organisms suggests a coevolution with their respective mammalian hosts in which their preferred lifestyle is commensal-like. 1 In immunologically intact mammals, Pneumocystis spp. exert little to no pathogenic effects, but if the host loses immune functionality, by disease or chemotherapeutic agents, the organisms can take advantage of the shift in the host: pathogen relationship, becoming an opportunistic pathogen, which in some cases can be associated with clinical signs of pneumonia. 1 From a taxonomic perspective, only five Pneumocystis entities have been formally accepted as individual species: P. carinii and P. wakefieldiae in brown rats, [3] [4] P. jirovecii in humans, [5] [6] P. murina in common mice, 7 and P. oryctolagi in rabbits. 8 Although the term 'Pneumocystis carinii formae speciales canis' is currently the most appropriate term to describe the species responsible for infection in dogs, for simplicity we will use the term 'Pneumocystis canis,' as proposed. [9] [10] In dogs, pneumocystis pneumonia (PCP) is a lifethreatening disease 2, [11] [12] [13] [14] [15] resulting from the effects of multiple organisms within the alveolar spaces, combined with the associated inflammatory response in the pulmonary interstitium. 2, [16] [17] [18] [19] [20] The suspected means of transmission for this potential pathogen is airborne droplet transmission from subclinically infected (asymptomatic) dogs, typically from bitch to pup soon after birth. 2 Asymptomatic colonisation by P. canis likely represents the most typical manifestation of canine infection, although data are currently unavailable concerning its prevalence in healthy dogs. Although Pneumocystis canis pneumonia has been diagnosed in smooth and wire-haired Miniature Dachshunds in Australia, Papua New Guinea, South Africa, and the United States [16] [17] [18] [19] and in Pomeranians in Japan, 21 the majority of cases are currently encountered in young adult Cavalier King Charles Spaniels (CKCS). This probably represents both the popularity of the breed in the stated jurisdictions and a genetic propensity for individuals in this breed to develop PCP. 20 The first detailed case report of PCP in CKCS was provided by Canfield and colleagues from the University of Sydney. 18 Although this predisposition is said to be attributable to IgG deficiency in this breed, 20 the coexistence of demodecosis in many affected dogs of this breeds suggests to us there is an additional issue with either innate immunity or cell-mediated immune responses. Diagnosis can be challenging in a veterinary context and traditionally has required the identification of P. canis 'cysts' or 'trophic forms' (formerly called trophozoites) in deep bronchial washings, bronchoalveolar lavage fluid (BAL) or transthoracic fine needle aspirates of lung. It is not uncommon for deep bronchial washings or BAL fluid to contain so few Pneumocystis morphotypes that a cytologic diagnosis is not possible, even when the index of suspicion is high because of breed associations and characteristic radiographic findings accompanied by hypoxaemia.
Development of polymerase chain reaction (PCR) assays for canine Pneumocystis strains is a research priority, because in our experience, protocols developed for the human species P. jirovecii 22 and panfungal PCR assays 23 do not reliably detect Pneumocystis spp. associated with canine infections. 2, 10 In order to explore the best molecular approach, in terms of fungal gene targets and PCR protocols, we first investigated the presence of P. canis in eight lung specimens from dogs in which a definitive diagnosis of PCP had been made based on cytology or histopathology, by applying PCR protocols used for genotyping P. jirovecii in human patients 24 and P. carinii in wild animals. [25] [26] [27] Following on from these preliminary investigations, our aim was to investigate P. canis in lung specimens using PCR targeting portions of the mitochondrial small subunit (mtSSU) and large subunit (mtLSU) of the rDNA gene cluster in three canine groups: (i) dogs with confirmed PCP or strongly suspected of having PCP, (ii) dogs with other lower respiratory tract problems, (iii) dogs that had died because of vehicular trauma but were not suspected of having any preexisting lung condition. In addition, in order to investigate if asymptomatic colonisation vs infection occurs in dogs, we also developed a SYBR Green real-time quantitative polymerase chain reaction (qPCR), targeting a short fragment of the mtSSU (150 bp). The qPCR increased sensitivity for detecting P. canis DNA in lung specimens and provided a semiquantitative estimate of fungal load.
Methods

Study groups
In this study, we considered three groups of dogs according to the following criteria:
(i) Group 1: Dogs (n = 16) with confirmed PCP or strongly suspected of having PCP: dogs were considered 'suspected' PCP cases (n = 6) based on physical findings, hypoxemia, breed, signalment, history (e.g., demodectic mange, immunosuppression, underlying conditions), radiologic findings, improvement with trimethoprim-sulfonamide therapy, while confirmed PCP cases (n = 10) additionally had cytologic or histologic demonstration of Pneumocystis cysts and/or trophic forms in BAL fluid or lung biopsy specimens.
(ii) Group 2: Dogs (n = 65) with non-PCP lower respiratory tract disease: dogs with 'laboured breathing and 'respiratory distress' but considered unlikely of having PCP based on thoracic radiographs and absence of Pneumocystis cysts and/or trophic forms on cytologic examination of BAL fluid specimens (iii) Group 3: Dogs (n = 11) not suspected of having PCP: these dogs died of vehicular trauma with absence of macroscopic findings in lungs at post mortem examination and were sampled opportunistically. BAL fluid was not obtained from these dogs post-mortem, nor were histological sections examined.
Specimens
Archived methanol-fixed Diff-Quik R or Wrights-stained microscope slides (n = 14), formalin-fixed paraffinembedded (FFPE) tissue blocks (3) and BAL fluid specimens (5; obtained prospectively) were available from 16 dogs with confirmed or suspected PCP (Group 1). The number and type of specimens from each dog are reported in Table 1 . These specimens were submitted to diagnostic laboratories in Australia (7 cases), the United States (6), and Italy (3), between 1992 and 2016. Signalment, historical, and clinical findings for the 16 likely PCP cases are summarized in Table 1 . In order to investigate the occurrence of Pneumocystis in dogs without clinical PCP, 65 BAL specimens were examined from dogs with 'laboured breathing or 'respiratory distress' but unlikely to have PCP (Group 2), while lung tissue specimens (11) were obtained from canine necropsy examinations at the Istituto Zooprofilattico Sperimentale delle Venezie (IZSVe) from dogs that died following vehicular trauma (Group 3). Signalment, historical and clinical findings for these 76 dogs (Group 2 and Group 3) are summarized in Supplementary Table S1 . BAL fluid and lung tissue samples were preserved at −20
• C prior to DNA extraction and PCR testing. BAL fluid specimens from the 65 dogs in Group 2 were vortexed and separated for DNA extraction. Cytology preparations from each dog had already been performed at the referral centre where dogs were admitted for veterinary attention. After BAL centrifugation, 50 µl of pellet was pipetted on a slide, air dried, fixed in methanol, and stained using Diff-Quik R . Impression smears were prepared from only a single lung tissue specimen (Group 3). All DiffQuik R -stained smears were examined using conventional light microscopy (Labophot-2 Nikon) under oil immersion to observe the presence and density of Pneumocystis cysts and trophic forms.
Molecular analyses
DNA extraction from (i) microscope cytology slides, (ii) BAL fluid, (iii) lung tissue specimens, and (iv) FFPE tissue blocks DNA was extracted using a commercial spin kit (DNAeasy Blood & Tissue Kit; QIAGEN, Germany), following the manufacturer's recommendations, with preparation of specimens as described below. Extracted DNA was resuspended in 100 µl elution buffer and stored at −20
• C. A negative control was included systematically in each series of DNA extractions. All specimens were extracted in duplicate.
(i) Cytology slides The methodology of Reppas et al. 28 was utilized, with slight modification. Briefly, phosphate-buffered saline (PBS; 300 µl) was pipetted onto the glass slide and then the stained material was scraped from its surface with the pipette tip, aspirated and resuspended in PBS. (ii) BAL specimens BAL fluid (1 ml) was centrifuged (8,000g; 5 min) and the supernatant removed. Residual fluid (300 µl) containing the pellet was transferred to a 2-ml microcentrifuge tube containing two tungsten beads (each 3-mm diameter). A bead-beating step was applied for 1 min at 30 Hz (TissueLyser systems device; Qiagen Retsch GmbH, Hannover, Germany) to increase DNA yield.
(iii) Lung tissues
For each dog, two representative portions of unfixed lung tissue (25 mg each) were used to extract DNA, as described previously. 
PCR protocols 1. Multi-locus sequence typing (MLST)
We investigated the presence of P. canis in eight specimens (BAL and lung tissue) from dogs with confirmed PCP (Cases 1-8; Pneumocystis jirovecii, P. carinii f.sp. Apodemus flavicollis (KR704340), and P. carinii f.sp. river rat (KR704345) positive-control DNA were included in each assay.
Nested mtLSU and mtSSU PCR (P360)
Portions of the mtLSU and mtSSU (Table 1) of the rRNA gene cluster were amplified by nested PCR using primers and conditions reported previously. 27 Amplified fragments were 320-340 bp and 360-380 bp in length, respectively. The nested mtSSU PCR was named and reported as Protocol 360 (P360) in Tables and Fig- ures throughout the manuscript.
P130 protocol
In order to increase the sensitivity of the PCR assay, a set of new primers PneuSSU189 (5 -CTTTAGTTCGTGTTGTGAAATG-3 ) and Pneu SSU362 (5 -TAAGGGTCATGAGGACTTGTC -3 ) were designed to amplify a short fragment (130-150 bp) of mtSSU rRNA. This genetic target is located between the primers pAZ112-13RI and PAZ112-14RI ( Fig. 1 ). Primers were designed manually, according to general primer design rules 31 based on a sequence alignment of reference sequences from different Pneumocystis spp. available from the NCBI database (http://www.ncbi.nlm.nih.gov), including canine mtSSU sequences obtained in the first part of this study using the nested mtSSU PCR (P360) (see Supplementary Table S2 ). The sequence specificity of the primers used was confirmed in a BLASTn search 32 against GenBank. The P130 protocol was tested in parallel using both conventional and real-time PCR.
(i) P130 conventional PCR PCR was performed in a 50-µl volume consisting of 1× PCR buffer (Applied Biosystems, Foster City, CA), 2 mM MgCl 2 (Applied Biosystems, Foster City, CA), 0. 
P230 protocol
A 230-240 bp fragment of the mtSSU rRNA was amplified using PneuSSU189f (5 -CTTTAG TTCGTGTTGTGAAATG-3 ) and PAZ112-14RI (5 -GGGAATTCTTCAAAGAATCGAGTTTCAG-3 ) 33 primers with the same PCR mixture and conditions reported for the classic P130 PCR protocol (Fig. 1) . The P230 PCR protocol was used only on specimens that were P130-positive but nested PCR (P360)-negative, in order to generate a longer PCR product from the same isolate for phylogenetic purposes. All 92 specimens were screened using both the nested mtSSU (P360) and P130 protocols. In addition, P130-positive but nested PCR (P360)-negative specimens were tested by the P230 protocol. All positive amplicons were sequenced to confirm that Pneumocystis DNA was actually being amplified. 
DNA purification and sequencing
Phylogenetic analysis
Three unrooted trees were constructed, using the Maximum Likelihood method using 1000 Bootstrap replicates implemented in MEGA6. 34 Tamura 3 parameter and G distribution, Hasegawa-Kishino-Yano and Gamma distribution were used as best models. Accession numbers of Pneumocystis sequences used, including sequences produced in study, are presented in Supplementary Table S2 .
Statistical analyses
The agreement between P360 and P130 protocols was tested using kappa coefficient (k) 35 using SPSS for Windows (version 13.0).
Results
Canine patients
Clinical material from a total of 92 dogs were included in this study. Sixteen dogs (Group 1) had both clinical and radiologic signs consistent with PCP. The remaining 76 dogs (Group 2, Group 3) were either healthy (prior to their death by vehicular trauma) (Group 3) or had some other cause of lower respiratory disease unrelated to pneumocystosis (Group 2). Most dogs in Group 2 were presented to a referral veterinary centre because of 'chronic cough' and/or 'severe pneumonia' that had not improved with empiric antibiotic therapy (typically amoxicillin clavulanate plus enrofloxacin), and in which thoracic radiographs and BAL fluid cytology were not consistent with pneumocystosis. Dogs with confirmed or suspected PCP (Group 1) were composed of 10 CKCS, and one each of the following breeds or crossbreds: Kelpie, Boxer, Border collie, Chihuahua, miniature Dachshund, and Maltese/Papillion cross. Most of these dogs were young, ranging in age from 1 to 7 years (median 3 years). Nine dogs were female, seven were male. The subcohort of CKCS ranged in age from 1 to 6 years, with a median age of 2 years and comprised six males and four females. Only one dog, the Maltese Papillion crossbreed, was receiving immunomodulatory therapy (toceranib). Considering these 16 dogs, Pneumocystis morphotypes (cysts -9 cases and/or trophic forms -1 case) were observed in stained smears (Diff-Quik, Wrights, or Geimsa) from BAL specimens or lung aspirates and/or haematoxylin and eosin (H&E)-stained tissue sections from 10 to 16 dogs. No Pneumocystis organisms were observed in cytologic preparations from 6/16 dogs ( Table 2 ). The burden of Pneumocystis morphotypes were classified as (i) numerous (n = 8 dogs; Fig. 2a, b , e, f) and (ii) occasional (n = 2 dogs; Fig. 2d ) (Table 2). In 9/10 positive smears Pneumocystis morphotypes were described as 'cysts' and 'trophic forms', but in Case 7 only trophic forms were apparent (Fig. 2c) .
Molecular analyses
Pneumocystis DNA was amplified from 17 dogs (13/16 Group 1 dogs, 3/65 Group 2 dogs and 1/11 Group 3 dogs, including DNA extracted from material scraped off DiffQuik R or Wrights-stained slides (five dogs), shavings from FFPE lung tissue (three dogs), BAL fluid specimens (eight dogs), and fresh lung tissue (one dog).
MLST, nested mtLSU and mtSSU rRNA PCR
Nested mtSSU and nested mtLSU PCR protocols succeeded in amplifying Pneumocystis DNA from canine specimens, whereas no DNA could be amplified using MLST scheme primers and protocols developed for the human pathogen P. jirovecii. Pneumocystis DNA was amplified from a single dog (Case 4; 1/8 specimens tested) using the mtLSU rRNA gene cluster target. This nested PCR was, however, unsuccessful in an additional seven instances and consequently was rejected as a target for further testing (Table 1) . Pneumocystis DNA was amplified by a nested mtSSU rRNA PCR (P360) from 12/16 PCP dogs (Group 1, Table 1 ). No DNA was amplified using the P360 protocol from the 76 dogs with non-specific lower respiratory tract diseases (Group 2) and dogs not suspected of having PCP (Group 3) (Supplementary Table S1 ).
P130 protocol
All 92 specimens were investigated using the more sensitive P130 protocol, by both conventional PCR and qPCR assays. Pneumocystis DNA was amplified from 17 dogs (17/92) including 13 cases with PCP (Group 1) and 4 dogs unlikely to have symptomatic PCP (subclinical PCP, i.e., colonization; 3 from Group 2 and 1 from Group 3). Agreement between P130 and nested mtSSU P360 protocols was good (k = 0.733). The P130 assay was more sensitive, detecting small quantities of Pneumocystis DNA in four dogs (3 from Group 2 and 1 from Group 3; Cases 36, 42, 81, 86; Supplementary Table S1) that tested 'negative' using the nested mtSSU PCR (P360; Supplementary Table S1). There was excellent agreement between the conventional and real-time P130 PCR assays (k = 0.961). The only discordant result was a PCP patient (Case 11; Table 1 ), where Pneumocystis DNA amplified weakly using qPCR but was negative with all other PCR protocols.
The qPCR assay performed very well in Pneumocystis identification by generating a single melting peak at 76
• C ± 0.5
• C with C T < 35, without formation of important primer-dimer interferences. According to melt analysis, it was possible to categorise specimens as either 'positive' or 'negative'. Among positive specimens, we designated that C T values ≤26 were suggestive of a 'high parasite load' and C T ranges of >26 but <35 were consistent with a 'low parasite load'. C T values ≥35 were considered 'negative'. Both conventional and qPCR assays demonstrated good reproducibility using high (Case 4) and low (Case 3) Pneumocystis load specimens ( (Fig. 3) . Amplicons of mtSSU were obtained from 12 to 16 PCP dogs (Group 1) using the P360 protocol. Sequences were shown to be identical to the carnivore group (Fig. 4) . In GenBank, no canine mtSSU rRNA Pneumocystis sequences were available for comparison with sequences obtained from the present 12 affected dogs. In both mtSSU and mtLSU dendrograms constructed without an outgroup, the backbone showed poor support for the deepest nodes, but terminal clades were well resolved at bootstrap values of >95%. Clustering of partial mtSSU was done using GenBank submissions to show the diversity of the aforementioned sequence types compared to known Pneumocystis species (Supplementary Table S2 ). In addition, among the carnivores, a well-supported group of dogs was recognizable with both markers. BLASTn analysis of the P130 PCR amplicon resulted in a low similarity (90%) with both P. jirovecii and P. carinii from nonhuman primates. Such a result is not uncommon when a new species is described, and the database contains limited sequences of the same target, with few species for comparison. The 230 bp fragment from the same specimens showed comparable low sequence similarity but with more Pneumocystis species, such as P. jirovecii, P. murina, and P. carinii. These observations confirmed that the newly designed primers are more homologous to P. canis and should therefore be more specific for this organism. Sequences obtained with nested P130 and P130 qPCR protocols from single specimens were invariably identical. An unrooted tree, constructed using representative P130, P230, and qPCR sequences, showed a well-supported 'canine' clade (bootstraps value >97%) separate from Pneumocystis spp. of other mammal hosts, as shown previously for the mtSSU (P360) tree (Fig. 5) . This observation confirmed the phylogenetic accuracy and specificity of this short fragment as a putative P. canis marker.
Discussion
Pneumocystis canis is an opportunistic extracellular pathogen of the canine lung. Extrapolating from other species, low levels are likely to be present in the lung of a proportion of normal immune-competent dogs. In dogs with deficiencies of innate immunity, or acquired antibody and/or cell mediated immunity, P. canis has the capacity to multiply largely unchecked, giving rise to interstitial pneumonia, in part due to the effect of the fungal organisms per se, and in part due to the impact of the florid but ineffective host immunologic response. Although comparatively few cases have been reported, the clinical entity of canine PCP has been well characterized, and the over-representation of certain breeds (viz. CKCS, miniature Dachshunds, and their hybrids) is striking. In susceptible individuals, PCP represents a serious disease with a potentially fatal outcome. Clinicians must therefore have a high index of suspicion for this diagnosis when confronted with dogs with a consistent clinical picture.
Diagnosis of PCP is difficult due to the absence of any specific alterations in hematologic or biochemical measurements or pathognomonic changes in thoracic radiographs. A diffuse interstitial lung pattern, bordering on a diffuse alveolar pattern, is suggestive of PCP, and often signs of pulmonary hypertension and cor pulmonale are evident also. 18 CT changes compatible with diffuse interstitial disease (ground glass opacification) are characteristic, but imaging usually requires general anesthesia or heavy sedation, which may not always be in the patient's best interest. Definitive diagnosis of P. canis pneumonia is traditionally based upon direct visualization of causative organisms in cytology smears made from BAL fluid, deep bronchial washings, or transthoracic fine needle aspirates during acute disease. Different staining techniques offer variable sensitivity and specificity for this purpose, while indirect immunofluorescence can further improve the ability to detect Pneumocystis forms in microscopic preparations. In human patients, all these techniques have proven to be less sensitive than qPCR for the diagnosis of Pneumocystis pneumonia. [36] [37] [38] Molecular protocols developed to diagnose P. jirovecii in humans have consistently failed in our hands when used for investigations into Pneumocystis disease in other mammals. This presumably is due to the heterogeneity of Pneumocystis organisms characterized by phylogenetic divergence according the host species. 39 A broad-based 'panfungal PCR' appeared to have insufficient sensitivity to diagnose PCP in dogs using BAL fluid specimens, even when cysts were detected in stained cytological preparations 10 ; the reasons why this is so are unclear.
At the start of our investigations, we studied Pneumocystis in eight specimens in which the diagnosis was unequivocal, one each from eight different dogs (consisting of FFPE tissue specimens, cytology slides, and BAL fluids) using molecular protocols previously reported for animals and humans. Only mitochondrial fragments of Pneumocystis (mtSSU and mtLSU) could be successfully amplified. The mtLSU fragment could be amplified from a single specimen (1/8), while mtSSU was amplified from 8/8 specimens tested, suggesting it was a superior candidate marker. The well-supported mtSSU clade in the phylogenetic tree suggests that the Pneumocystis species harbored in dogs is specifically 'canine'-related and well separated from other mammalian Pneumocystis species. This finding was confirmed by the phylogenetic tree constructed using mtLSU (Fig. 4) or shorter mtSSU fragments (P130, P230; Fig. 5 ). The single sequence type found in all cases suggests that no heterogeneity is observed amongst P. canis isolates when mtSSU is selected as the target.
Given these observations, a P130 protocol was selected over the nested P360 PCR to develop a conventional PCR and SYBR Green qPCR. Both methods proved to be sensitive and specific tools for the molecular diagnosis of canine PCP using clinical specimens that can be readily obtained by veterinary practitioners in the field. Indeed, this protocol excluded amplification of other fungi (Cryptococcus spp., Aspergillus spp., Fusarium spp., Penicillium spp., Candida spp.) and bacteria (such as Bordetella bronchiseptica, Pasteurella multocida) potentially present in the tracheobronchial tree or lungs of dogs as pathogens or saprophytic colonizers. In addition, this qPCR permits identification of P. canis by generating a product with a single melting peak at 76
• C, which avoids the requirement for sequence analysis. Furthermore, it gives reliable quantitative information (C T value) about Pneumocystis DNA in the specimen with good (but not absolute) concordance with presence and abundance of Pneumocystis morphotypes in cytologic and histologic preparations and other PCR protocols (Table 2) . Some comparative Pneumocystis studies in various species have used the nested mtLSU PCR protocol to distinguish between low and high parasite loads, indicating a 'high parasite load' when Pneumocystis DNA amplified by the first PCR step, and a 'low parasite load' when DNA amplification is visualized only after the second, nested, PCR step. [40] [41] According to this scheme, the low parasite state is suggestive of colonisation by Pneumocystis i.e. an asymptomatic carrier state (commensalism). This is in good agreement with our findings, where a 'high Pneumocystis load' was evident when specimens were positive with all PCR protocols (including nested mtSSU PCR; P360) and a 'low Pneumocystis load' when specimens were P130-and P230-positive but negative with a nested mtSSU PCR. Accordingly, we observed five dogs with 'low parasitic loads,' of which four belonged to the group considered unlikely to have PCP based on clinical criteria (Table 2) . Similar considerations apply if we evaluate the abundance and nature of Pneumocystis morphotypes in specimens in relation to the C T value observed with qPCR. The data suggest that 'high Pneumocystis load' and 'numerous organisms' observed microscopically were associated with low C T values (≤ 26) in eight dogs, while 'low Pneumocystis load' was described for nine dogs with intermediate C T values (> 26 but < 35) and 'occasional' or 'absent' Pneumocystis organisms observed microscopically. These preliminary findings introduce the critical concept that dogs can be colonised by a low P. canis burden, the same situation as in most mammalian species and their specific Pneumocystis species. 1 There are, however, a number of technical issues that might account for the discrepancy between C T values and Pneumocystis morphotype abundance in cytology preparations. When PCP is less severe, typically earlier in the disease course, organisms are less abundant, and even deep bronchial washings or BAL may not acquire a sufficient number of cysts or trophic forms to ensure detection by a cytologist. As Pneumocystis resides mainly in the alveolar spaces rather than the airways, technical expertise is required to ensure the BAL or deep bronchial washing specimen is obtained with sufficient vigour to ensure the sampling of P. canis organisms. For this reason, some clinicians favor percutaneous needle aspirates of lungs over BAL for the cytologic diagnosis of PCP, and our technique of obtaining DNA from methanol-fixed Diff-Quik-stained cytology smears means such specimens are suitable for confirmatory qPCR testing. 28 In human medicine, qPCR has allowed introduction of the concept of 'colonisation,' corresponding to the detection of P. jirovecii DNA in respiratory specimens from patients without clinical or radiologic signs of pneumonia. 42 To facilitate interpretation of Pneumocystis PCR results and to differentiate pneumonia from colonization, cut-off values of P. jirovecii DNA copy numbers or C T values have been suggested. 42 Definitive conclusions cannot be reached concerning the interpretation of C T values for a given patient, because C T values could differ by more than three cycles for the various available qPCR assays. 43 The logical inference is that progression from colonization to infection occurs in dogs with PCP, as it does in humans and rodents, with a spectrum of pneumocystosis burdens. According to our preliminary results, symptomatic life-threatening PCP is usually associated with Pneumocystis canis organisms detectable in Diff-Quik-stained smears using light microscopy, provided a sufficiently diligent search is made using well collected specimens. Likewise, such cases should be detectable using molecular tools, with any of the aforementioned protocols. With respect to BAL fluid specimens, sensitivity is affected by the quality of the specimen, which can vary widely due to technical aspects, including the size of the patient, the range of scopes available, and the skill of the bronchoscopist, as well as the severity and distribution of lung involvement. In general, visualization of characteristic cysts or trophic forms in BAL specimens or fine needle aspirate biopsies is considered diagnostic. But it must be considered that all Pneumocystis spp. have two developmental stages: the trophic form (formerly trophozoite) and the cyst form. The imbalance between the different life cycle forms of P. canis might explain the lower diagnostic yield of cytology in certain instances, as cysts are much easier to distinguish than trophic forms using rapid, modified Romanowsky stains such as Diff-Quik. Such an explanation might account for why some specimens in this series were PCR-positive, yet no organisms could be detected using conventional light microscopy. Interestingly, in rodent models, the trophozoite to cyst ratio increases during recovery from Pneumocystis carinii pneumonia, 44 yet this change could not be appreciated using sequential monitoring of bronchoalveolar fluid specimens from dogs. Thus, the present results must be interpreted with care.
PCR testing of BAL fluid or lung aspirates for P. canis is currently uncommon in commercial veterinary laboratories but should probably be attempted more often 9, 45 in order to definitively diagnose P. canis infection, especially at earlier stages of infection. 9, 10 In time, it should be possible to incorporate the qPCR primers used in the current study into commercially available multiplex qPCR testing protocols used to evaluate BAL specimens in canine medicine. The qPCR is also eminently suitable for use with fine needle lung aspirates, using material present in methanol-fixed Diff-Quik-stained smears. In some cases, it is conceivable that throat swabs might be PCR positive for P. canis (as they are in human patients), which would obviate the need for general anesthesia (with attendant risks) to confirm a presumptive diagnosis of PCP. 46 A characteristic feature of the genus Pneumocystis is the species-specific identity of infectious forms, with each mammalian host having its own unique Pneumocystis species as a commensal and/or potential pathogen. 1 A further feature of the genus is that the infectious agents are not cultivatable on routine mycological media, although growth is possible with special respiratory epithelial cell lines in tissue culture. 47 To understand the spectrum of potential disease for Pneumocystis species, a different conceptual approach to diagnosis is required compared to most other fungal pathogens, although there are cogent similarities with the Cryptococcus neoformans/gattii species complex. 48 Clearly, molecular diagnostics are essential, with the correct genetic target being critical for the successful development of a robust diagnostic tool of sufficient sensitivity and specificity. According to the present results, which encompass a large and representative range of case material, qPCR has sufficient specificity to be suitable as an early screening test for the presence of P. canis in BAL and lung aspirate specimens from dogs. We would suggest using qPCR for identification of P. canis in such specimens, referring to the melting peak at 76
• C ± 0.5 • C. Alternatively, specimens might be screened using the P130 protocol by conventional PCR, then confirmed by P. canis DNA amplification using the P230 protocol. The veterinarian should interpret the C T value in relation to the context of the patient's signalment (at risk breed?), history (demodectic mange?), physical examination, and radiologic findings when attempting to make a definitive diagnosis of PCP.
